Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Endovasc Ltd. (OTC BB:ENDV.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Insider | Financials
Recent Events
Aug 21Price hit new 52-week low ($0.02)
Location
15001 Walden Road, Suite 201
Montgomery, TX 77356
Phone: (936) 448-2222
Fax: (936) 582-2250
Email: bjr@endovasc.com
Employees (last reported count): 14
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 61%
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Endovasc Ltd. develops, markets, and licenses biopharmaceutical products, particularly liposomal drug delivery methods, for the human healthcare industry. Endovasc develops liposomes, which are microscopic cell-like spheres composed of a thin, durable lipid membrane surrounding a hollow compartment. Liposomes entrap and protect drugs from degradation in the blood stream and can be engineered to regulate the transport of molecules across their outer membrane. Using this technology, the Company is developing products that deliver drugs to their intended target and release them with efficiency and control. The Company's product development currently is focused on two product lines: Liprostin and Nicotine Receptor Agonist. Although its current development efforts focus on vascular (heart and lung) applications of its products, the Company intends to develop these technologies for use in many medical treatment applications.
More from Market Guide: Expanded Business Description

Financial Summary
Endovasc Ltd. is a biopharmaceutical company using liposomal drug delivery for products that have already shown safety and efficacy in generic form, and other products for increased circulation in limbs and to the heart. For the nine months ended 3/31/01, revenue totaled $90 thousand, up from $24 thousand. Net loss rose less than 1% to $1.8 million. Results reflect revenues from a feasibility study, offset by increased personnel and overhead expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]

Position
David Summers, Ph.D.Chairman, CEO
Gary BallCOO, VP-R&D, Treasurer
Roy RobertsonVP-Bus. Devel.
M. Dwight CantrellController, CFO
Danilo Lasic, Ph.D.CSO
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:ENDV.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 21-Aug-2001
$0.02 
Recent Price$0.032
52-Week High
on 5-Sep-2000
$1.25 
Daily Volume (3-month avg)577.5K
Daily Volume (10-day avg)880.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-97.2%
52-Week Change
relative to S&P500
-96.2%
Share-Related Items
Market Capitalization$721.0K
Shares Outstanding22.5M
Float8.80M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.04 
Earnings (ttm)-$0.33 
Earnings (mrq)-$0.04 
Sales (ttm)$0.01 
Cash (mrq)$0.00 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)4.36 
Income Statements
Sales (ttm)$97.0K
EBITDA (ttm)-$3.83M
Income available to common (ttm)-$3.92M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter31-Mar-2001
Management Effectiveness
Return on Assets (ttm)-567.36%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)0.05 
Debt/EquityN/A 
Total Cash (mrq)$54.0K
Short Interest
Shares ShortN/A 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.